Cullinan Therapeutics to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Aug 21, 2025
CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced its participation in the following upcoming investor conferences:
Read more at globenewswire.comNASDAQ:CGEM (9/5/2025, 10:38:07 AM)
6.9
-0.01 (-0.14%)
Find more stocks in the Stock Screener
